RECIST criteria play a critical role in the drug development process. They are used in early-phase trials to identify promising therapeutic agents and in later-phase trials to provide evidence of clinical benefit. Consistent application of RECIST criteria across studies helps in regulatory approval processes and in defining response rates that guide further research and development.
